Treatment at relapse for synovial sarcoma of children and adolescents: A multi-institutional European retrospective analysis.

Pediatric patients with relapsed SS have a poor prognosis and generally receive an individualized approach, due to the lack of a uniform standardized approach. New comprehensive strategies are needed to improve the knowledge on the biologic landscape of SS and develop tailored prospective clinical trials.